This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Hepzato

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Hepzato Means in Everyday Medical Language

Hepzato is a brand name for a chemotherapy drug called melphalan hydrochloride. It is used specifically as a liver-directed treatment for adults with uveal melanoma, a rare type of eye cancer. This cancer has spread to the liver but cannot be removed by surgery. Hepzato is given as an infusion directly into an artery that supplies blood to the liver. By delivering the drug this way, it targets liver tumors more precisely while limiting effects on the rest of the body. The drug works by damaging the DNA inside cancer cells, which helps stop them from growing and dividing.

Why Hepzato Can Matter in Cancer Care

Uveal melanoma that spreads to the liver can be difficult to treat because surgery is often not an option. Hepzato offers a treatment option for patients whose liver metastases affect less than half of the liver and who have no or limited spread of cancer outside the liver that can be treated by surgery or radiation. This targeted approach helps focus treatment on tumors in the liver and may help control the disease or relieve symptoms. Hepzato is part of a broader cancer care plan and may be combined with other treatments depending on the patient’s situation.

What Patients Might See or Hear About Hepzato

Patients might hear the name Hepzato when discussing treatment options for uveal melanoma that has spread to the liver. They may also see it listed in their treatment plan, medication list, or clinical trial information. Because melphalan hydrochloride is used under different brand names for different cancers—such as Evomela for multiple myeloma—patients might hear about these names together. It is important to understand that Hepzato is not a cure and is approved for specific uses. Its presence in a treatment plan does not guarantee a particular outcome.

Common Sources of Confusion and Questions to Ask

Because melphalan hydrochloride comes in different forms and brand names, patients and caregivers might confuse Hepzato with other chemotherapy drugs or misunderstand its role. It is helpful to ask the care team questions such as: “Why is Hepzato recommended for me?” “How will it be given?” “What side effects should I expect?” and “How does this treatment fit with other therapies I am receiving?” Understanding how Hepzato fits into the overall treatment plan can help patients feel more informed and prepared.

How to Read the Term Hepzato in Context

Hepzato should not be seen as a diagnosis or a standalone treatment recommendation. If the term appears in a medical report, treatment summary, or clinical trial description, the best step is to ask the care team what it means for the individual patient’s care. This helps avoid misunderstandings and ensures that patients know how Hepzato relates to their specific situation.

Safety and Next Steps

This information about Hepzato is educational and does not replace medical advice. Each patient’s case is unique, and treatment decisions depend on many factors. If you or a loved one is prescribed Hepzato or sees it mentioned in medical documents, talk with your healthcare providers to understand its role, benefits, and risks. Asking questions and discussing concerns will help you make informed decisions about your care.

Sources

Public source information used for this glossary entry includes: